Professional
Added to YB: 2024-11-27
Pitch date: 2024-11-27
EVO [neutral]
Evotec SE
-7.84%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
Market Cap
EUR 1.7B
Pitch Price
EUR 9.13
Price Target
N/A
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
value
Evotech: Biotech Growth Play at a Discounted Sales Multiple
EVO: Drug discovery platform. Recent €11/share buyout rumors by HALO, management blocked. Now €9.24, lowest since 2017 despite 3x revenue. NVO invested at $21/share. Biotech downcycle due to rates, but <3x sales multiple seems low given growth and margins. Management sees higher fair value.
Read full article (1 min)